An electronic health record driven algorithm to identify incident antidepressant medication users

Journal of the American Medical Informatics Association

Volumn 21, Issue 5, 2014, Pages 785-791

  Bobo, William V ^a   Pathak, Jyotishman ^a   Kremers, Hilal Maradit ^a   Yawn, Barbara P ^b   Brue, Scott M ^a   Stoppel, Cynthia J ^a   Croarkin, Paul E ^a   Sauver St , Jennifer ^a   Frye, Mark A ^a   Rocca, Walter A ^a  

^a MAYO CLINIC   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT;

ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; DRUG INFORMATION; DRUG USE; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; PATIENT IDENTIFICATION; POPULATION; PREDICTIVE VALUE; PRESCRIPTION; RANDOM SAMPLE; SEX DIFFERENCE;

ADULT; ALGORITHMS; ANTIDEPRESSIVE AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MEDICAL RECORD LINKAGE; MINNESOTA;

EID: 84906324058     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2014-002699     Document Type: Article

References (41)

1. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-31.
2. Olfson MM, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848-56.
3. Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) 2011;30:1434-42.
4. Hsiao CJ, Cherry DK, Beatty PC, et al. National Ambulatory Medical Care Survey: 2007 summary. Natl Health Stat Rep 2010;3:1-32.
5. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.
6. Levkovitz Y, Tedeschini E, Papakostas GI. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry2011;72:509-14.
7. Kapczinski F, Lima MS, Souza JS, et al. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003;(2):CD003592.
8. Bakker A, van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol 2005;8:473-82.
9. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006;(1):CD002795.
10. de Menezes GB, Coutinho ES, Fontenelle LF, et al. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.Psychopharmacology (Berl) 2011;215:1-11.
11. Jureidini J, Tonkin A. Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 2006;20:623-32.
12. Conti R, Busch AB, Cutler DM. Overuse of antidepressants in a nationally representative adult patient population in 2005. Psychiatr Serv 2011;62:720-6.
13. Chung S. Does the use of SSRIs reduce medical care utilization and expenditures? J Ment Health Policy Econ 2005;8:119-29.
14. Wisniewski S, Rush AJ, Nierenberg AA, et al. Can phase III results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry2009;166:599-607.
15. Depp C, Lebowitz BD. Clinical trials: bridging the gap between efficacy and effectiveness. Int Rev Psychiatry 2007;19:531-9.
16. Ray WA. Population-based studies of adverse drug effects. N Engl J Med 2003;349:1592-4.
17. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-20.
18. Rocca WA, Yawn BP, St Sauver JL, et al. History of the Rochester Epidemiology Project: half a century of medical records linkage in a United States population.Mayo Clin Proc 2012;87:1202-13.
19. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 2012;41:1614-24.
20. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837-49.
21. St Sauver JL, Grossardt BR, Leibson CL, et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012;87:151-60.
22. Bobo WV, Cooper WO, Stein CM, et al. Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study. BMC Med Res Methodol 2012;12:128.
23. Landry JA, Smyer MA, Tubman JG, et al. Validation of two methods of data collection of self-reported medicine use among the elderly. Gerontologist 1988;28:672-6.
24. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-12.
25. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991;39:1079-84.
26. Curtis JR, Westfall AO, Allison J, et al. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf 2006;15:710-18.
27. McKenzie DA, Semradek J, McFarland BH, et al. The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: the Oregon experience. J Clin Epidemiol 2000;53:1248-57.
28. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994;271:358-62.
29. Mangione-Smith R, Wong L, Elliott MN, et al. Measuring the quality of antibiotic prescribing for upper respiratory infections and bronchitis in 5 US health plans. Arch Pediatr Adolesc Med 2005;159:751-7.
30. Maselli JH, Gonzales R. Measuring antibiotic prescribing practices among ambulatory physicians: accuracy of administrative claims data. J Clin Epidemiol2001;54:196-201.
31. St Sauver JL, Grossardt BR, Yawn BP, et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.Am J Epidemiol 2011;173:1059-68.
32. Pathak J, Murphy SP, Willaert BN, et al. Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project. AMIA Annu Symp Proc 2011;2011:1089-98.
33. Zhong W, Maradit-Kremers H, St Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc 2013;88:697-707.
34. Savova GK, Masanz JJ, Ogren PV, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc 2010;17:507-13.
35. Varkey P, Resar RK. Medication reconciliation implementation in an academic center. Am J Med Qual 2006;21:293-5.
36. Varkey P, Cunningham J, Bisping DS. Improving medication reconciliation in the outpatient setting. Jt Comm J Qual Patient Saf 2007;33:286-92.
37. Johnson ES, Bartman BA, Briesacher BA, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf 2013;22: 1-6.
38. Cox E, Martin BC, Van ST, et al. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value Health 2009;12:1053-61.
39. St Sauver JL, Warner DO, Yawn BP, et al. Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc 2013;88:56-67.
40. Kremers HM, Myasoedova E, Crowson CS, et al. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) 2011;50:6-15.
41. Melton LJ III, Dyck PJ, Karnes JL, et al. Non-response bias in studies of diabetic complications: the Rochester Diabetic Neuropathy Study. J Clin Epidemiol 1993;46:341-8.